Cas No.: | 396091-77-3 |
Chemical Name: | Cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl], L-aspartate (1:x) |
Synonyms: | SOM230 L-aspartate |
SMILES: | NC(C(=O)O)CC(=O)O.NCCCCC1NC(=O)C(CC2C3C=CC=CC=3NC=2)NC(=O)C(NC(=O)C2CC(OC(=O)NCCN)CN2C(=O)C(NC(=O)C(CC2C=CC(OCC3C=CC=CC=3)=CC=2)NC1=O)CC1C=CC=CC=1)C1C=CC=CC=1 |
Formula: | C62H73N11O13 |
M.Wt: | 1180.309 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | A potent, stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors (pKi=8.2/9.0/9.1/<7.0/9.9 for sst1/2/3/4/5, respectively); effectively inhibits GHRH-induced growth hormone release in primary cultures of rat pituitary cells with IC50 of 0.4 nM, also potently suppresses GH secretion in rats.Cushing's DiseaseApproved |